1. Introduction
The unabated rise in cardiometabolic disorders such as heart disease, obesity, and type 2 diabetes mellitus necessitates novel approaches to reduce associated risk factors. In recent years, scrutiny has been placed on dietary factors with a particular emphasis on macronutrients (i.e., fat, protein, carbohydrate) [
1] and meal frequency [
2]. However, a growing body of evidence suggests that these strategies, while certainly relevant, may overlook potential roles of other metabolites in mitigating cardiometabolic disease risk [
3,
4].
Secondary metabolites are naturally occurring substances produced by plants to make them more competitive in their environments, thus increasing their survival. These metabolites have historically been an important source of medicinal compounds and have been utilized in developing a number of therapeutics for diverse disease states [
5]. Yerba maté is an herbal tea derived from dried leaves of the South American
Ilex paraguariensis plant and is widely consumed in South American countries such as Brazil, Argentina, Paraguay, and Uruguay. Yerba maté is a particularly rich source of secondary metabolites that have been implicated in improving cardiometabolic health. These compounds include purine alkaloids such as caffeine and theobromine, polyphenols such as phenolic acids and flavonoids, and terpenes such as saponins and carotenoids, as well as numerous minerals and vitamins [
5].
While some foods are known sources of secondary metabolites [
6], environmental and farming trends have resulted in the steady reduction of these beneficial molecules in the foods we consume [
7], increasing the need for obtaining secondary metabolites from supplemental sources. Supplements enriched with these and other secondary metabolites have been shown to improve aspects of cardiovascular [
3] and metabolic health [
6,
8], cognitive function [
9], and more [
10].
Indeed, yerba maté tea has been shown to favorably alter the lipid profile in humans [
11]. Phenolic compounds such as chlorogenic acids, a class of phenol that is uniquely elevated in yerba mate tea [
12], have been linked to several beneficial health outcomes such as lipid homeostasis and weight management, cardiovascular protection, and glucose control [
13]. Additionally, phenols and flavonoids have been shown to bolster antioxidant defenses [
14] and reduce inflammation [
15,
16], which likely contribute to yerba maté’s protective effects in aging.
Mitochondria are widely considered hubs of cellular metabolism for their essential role in energy production. Impairments in mitochondria have been demonstrated in and have been suggested to drive metabolic disease [
17]. Improving mitochondrial health, therefore, has been proposed as a means of mitigating disease. In this study, we explore the effects of a four-week-long exposure to yerba maté on mitochondrial bioenergetics and redox potential within skeletal muscle, adipose, and hepatic tissue and demonstrate yerba maté supplementation has beneficial metabolic effects that vary by tissue. In total, this work adds to a host of evidence demonstrating that whole-body and tissue-specific metabolism is alterable via dietary intervention.
4. Discussion
Previous studies from our lab have demonstrated that diet has the capacity to alter mitochondrial efficiency in adipose [
21] and brain tissue [
25]. This study adds further support that diet alters mitochondrial bioenergetics. Specifically, these data demonstrate that yerba maté affects mitochondrial efficiency in a tissue-specific manner such that maté consumption increases mitochondrial efficiency within skeletal muscle but decreases mitochondrial efficiency within adipose tissue. We interpreted both of these changes to be metabolically beneficial, as they agreed with our observation that yerba maté consumption protected mice against weight gain on a standard rodent diet (
Figure 1). We also observed beneficial tissue-specific shifts in hepatic redox potential (
Figure 4F), which further support our positive interpretations.
While CON mice gained a significant amount of weight over the four weeks of conditioning, MATE mice experienced no significant changes compared to their baseline weight (
Figure 1). This is consistent with other rodent and human studies that have demonstrated beneficial effects of yerba maté on lipid oxidation and weight management, at large [
26,
27,
28,
29] . Indeed, multiple studies have demonstrated anti-obesity effects of yerba maté in rodents fed obesogenic diets. For example, one study fed Swiss mice a high fat diet (HFD) for eight weeks [
30]. These mice were then divided into two groups and fed either water (vehicle control) or yerba maté for an additional eight weeks. Obese HFD-fed mice expectedly gained a significant amount of weight. This increase in weight was accompanied by systemic and hepatic insulin resistance and elevations in total cholesterol, high and low-density lipoprotein cholesterol, and triglycerides. Yerba maté treatment attenuated, and in some instances, completely reversed these effects. In a hamster model of diet-induced hyperlipidemia, yerba maté consumption lowered the concentrations of serum lipids by modulating the expression of genes of lipid oxidation and increasing the activities of lipoprotein and hepatic lipases [
27]. Another study in Wistar rats maintained on a standard rodent diet supplemented with teas made from raw (not industrially processed) or commercial (industrially processed) maté indicated no significant changes in body weight or plasma lipids over 30 days [
31]. However, despite the lack of weight loss, intra-abdominal fat pad mass was significantly reduced in the raw maté group and epididymal fat pad mass was significantly lower in both maté groups, indicating more efficient lipid oxidation. In our study, mice were also maintained on a standard rodent diet. However, we observed significant increase in body weight in CON mice that was not observed in Silva, et al.’s work [
31]. Although we did not directly assess changes in the mass of intra-abdominal or epididymal fat pads, the differences in weight we observed are suggestive.
Anti-obesity effects of yerba maté supplements have also been observed in human clinical trials. For example, a double-blind, placebo-controlled study administered capsules of either yerba mate extract or placebo to male and female subjects with obesity for 12 weeks [
32]. In this time, they observed significant reductions in body fat mass and percentage, and waist-to-hip ratio without any significant changes in safety parameters. These effects are supported by other trials [
33]. Treatment with herbal preparations containing yerba maté, such as YGD (Yerba maté, leaves of Ilex paraguayensis; Guarana, seeds of Paullinia cupana; and Damiana, leaves of Turnera diffusa) have also yielded reductions in body weight and body fat [
28,
29]. Andersen and Fogh observed a significant delay in gastric emptying after 45 days of YGD treatment taken before each main meal. They concluded this delay likely increased feelings of satiety and contributed to subsequent weight loss [
29]. The study by Harrold, et al. explored the effects of YGD and soluble fermentable fiber on appetite and energy intake by feeding participants an energy-controlled breakfast, administered the treatments, and measuring appetite and energy consumption during lunch [
28]. They observed significnat reductions in both hunger and energy intake with YGD treatment that was further amplified with the addition of soluble fiber. While reductions in energy intake due to appetite suppression may be a contributing factor to the weight loss we observed in the mice in this study, energy output was the focus of the work presented here, as we assessed changes in metabolic rates of skeletal muscle, adipose, and hepatic tissue.
Here, we quantified changes in mitochondrial oxygen consumption, indicative of oxidative metabolism. We expected to observe differences in their metabolic responses to MATÉ treatment because tissues inherently vary in their metabolic rates and functions. In skeletal muscle, no changes in oxygen consumption were observed with the addition of glutamate and malate, ADP, and succinate, substrates that feed into different complexes of the mitochondrial electron transport system (
Figure 2A). However, significant increases in ATP concentration (
Figure 2B) and ATP:O
2, a measure of mitochondrial efficiency, or ATP produced per unit of oxygen consumed (
Figure 2C) were observed. This increase in efficiency indicates a more “coupled” metabolic state in which oxygen consumption is more tightly coupled to energy production. Interestingly, we observed somewhat of an opposite phenomenon in white adipose tissue. Adipose oxygen consumption rates increased with yerba maté treatment, indicating an increase in metabolic rate. While ATP production increased in skeletal muscle, maté administration induced a significant decrease in ATP production in white adipose tissue (
Figure 3B). When combined with the changes in oxygen consumption, ATP:O
2 ratios strongly trended toward a significant decrease (
Figure 3C, p = 0.050007), or a more “uncoupled”, energetically inefficient state.
Although the effect of yerba maté on some aspects of exercise, such as muscle strength, remains controversial [
34,
35], maté-induced changes in skeletal muscle and adipose mitochondrial bioenergetics have previously been associated with positive health outcomes – improved low and high-intensity exercise performance [
36], and increased lipid oxidation and fat loss [
37]. Because yerba maté contains a number of bioavailable compounds, it is impossible to discern which compounds were directly responsible for these effects. However, weight loss observed with yerba mate consumption has been previously attributed to the caffeine content of the tea, which has been demonstrated to make up 1-2% of dry leaf weight [
38]. As a stimulant, caffeine has been shown to increase basal metabolic rate, improve aerobic performance and muscle oxygen content during exercise tests [
39], and increase lipid oxidation [
40,
41]. Additionally, caffeine has been reported to increase the
in vivo and
in vitro expression of adipose UCP1 (uncoupling protein 1), a mitochondrial uncoupling protein that releases energy stored in the mitochondrial proton gradient in the form of heat, in brown adipose [
42]. Although we did not quantify changes in white adipose UCP1 expression, the combination of our observations that yerba maté decreases white adipose mitochondrial efficiency and induces weight loss suggest mitochondrial uncoupling and loss of energy as heat. This has been shown to induce fat loss in humans and rodents and is consistent with studies that demonstrate yerba maté stimulates mitochondrial biogenesis, thermogenesis, and white adipose “browning” [
26]. This browning process makes white adipocytes phenotypically more similar to brown adipocytes, which are characterized by higher mitochondrial content and the expression of UCP1 [
43].
Mitochondrial dysfunction and downstream oxidative stress are considered hallmarks of aging [
44] and metabolic disorders [
45,
46]. Cellular homeostasis of oxidizing and reducing equivalents is normally maintained via enzymatic and nonenzymatic antioxidant systems that eliminate ROS and preserve cellular function. However, when the production of reactive oxygen species (ROS) exceeds cellular antioxidant defenses, redox states shift due to an increase in oxidizing equivalents and/or a decrease in reducing equivalents to promote a more oxidizing system. Oxidizing environments promoted oxidative modification of target macromolecules such as DNA, proteins, and lipids and impair cellular function [
47]. Glutathione is the most abundant intracellular antioxidant thiol [
48]. The GSH/GSSG couple is, therefore, commonly used as a proxy of cellular redox state and oxidative stress due to glutathione’s high concentration and involvement in first line antioxidant defenses and as a direct free radical scavenger [
47,
49]. Here, we report significant increases in GSH concentration in skeletal muscle (
Figure 2D) and liver (
Figure 4D) in response to yerba maté treatment, which may indicate a greater antioxidant buffering capacity. However, we only observed a significant change in GSH/GSSG E
h in the liver (
Figure 4F). The significant decrease in GSH/GSSG E
h observed in the liver indicates a beneficial shift toward a more reduced environment, suggesting an enhanced cellular homeostatic function. Although we did not directly quantify ROS, the shift in GSH/GSSG is suggestive of decreased oxidative stress, which could be due to a reduction in the production of ROS, an upregulation of antioxidant defenses and free radical scavenging, or possibly both. This would require further investigation; however, our findings are consistent with other studies that report yerba maté attenuates oxidative stress [
38,
50].
The liver is a central player in whole body energy metabolism for its roles in digestion and carbohydrate, lipid, and amino acid metabolism. The liver also has essential functions in the metabolism and elimination of xenobiotics. As such, antioxidants are necessary for hepatic function. Indeed, the liver is the largest source of GSH, which not only participates in the detoxification of xenobiotics and determines redox status, but has also been shown to regulate other essential cellular functions such as cell proliferation and apoptosis [
51]. Hepatic GSH production is impaired in liver diseases such as cholestatic liver injury, nonalcoholic fatty liver disease, and hepatocellular carcinoma as well as metabolic disorders such as obesity, insulin resistance, type 2 diabetes, and cardiovascular diseases [
52]. While oxidation of the GSH/GSSG E
h is associated with metabolic pathologies such as obesity, insulin resistance, type 2 diabetes, and cardiovascular disease, reduction of the GSH/GSSG E
h have been associated with hepatoprotection and a greater capacity to buffer oxidative stress. The favorable, pro-reducing shift in redox potential indicates an even greater, enhanced protection against oxidative stress.
Author Contributions
Conceptualization, J.M.H., B.T.B.; Methodology, C.M.W., E.R.S., J.M.H., and B.T.B.; Investigation, C.M.W., E.R.S., J.M.H., P.R.R., J.G.L., N.P.R. and B.T.B.; Formal Analysis, C.M.W., E.R.S. J.M.H., and B.T.B.; Writing—Original Draft Preparation, C.M.W., E.R.S. J.M.H., and B.T.B.; Writing—Review and Editing C.M.W., E.R.S., J.M.H., and B.T.B.; Project Administration, B.T.B.; Supervision, B.T.B.; Validation, C.M.W., E.R.S., J.M.H., and B.T.B.; Visualization, C.M.W., E.R.S., J.M.H., and B.T.B.; and Funding Acquisition, B.T.B. All authors have read and agreed to the published version of the manuscript.